Published in Proc Natl Acad Sci U S A on March 03, 1998
Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol (2009) 1.32
Lymphangiogenesis and cancer. Genes Cancer (2011) 1.16
Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement. Proc Natl Acad Sci U S A (1999) 1.06
Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol (2012) 1.00
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy. Clin Exp Nephrol (2014) 0.79
Insights into the paracrine effects of uterine natural killer cells. Mol Med Rep (2014) 0.77
Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Oral Oncol (2016) 0.75
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73
Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol (1995) 7.16
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature (1991) 3.87
Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat Immun Cell Growth Regul (1987) 3.45
Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33
Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity (1996) 3.18
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J (1996) 2.64
A role for the proteasome regulator PA28alpha in antigen presentation. Nature (1996) 2.30
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods (1994) 2.01
Natural killer cells: from no receptors to too many. Immunity (1997) 1.96
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J Biol Chem (1995) 1.70
Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med (1994) 1.69
Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A (1992) 1.62
Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity (1995) 1.58
Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res (1996) 1.55
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. J Immunol (1985) 1.51
Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J Exp Med (1996) 1.46
Radiochemical sequence analysis of biosynthetically labeled proteins. Methods Enzymol (1983) 1.43
Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A (1997) 1.29
Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression. J Immunol (1989) 1.25
Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest (1995) 1.23
Lymphocyte adhesion-dependent calcium signaling in human endothelial cells. J Cell Biol (1995) 1.20
Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J Biol Chem (1994) 1.16
Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science (1995) 1.14
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells. J Clin Invest (1987) 1.14
Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells. J Biol Chem (1997) 1.10
Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. J Immunol (1996) 1.07
How to recognize a foreign submarine. Immunol Rev (1997) 1.06
Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J Exp Med (1991) 1.04
T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. Proc Natl Acad Sci U S A (1990) 0.90
Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells. Cancer Immunol Immunother (1992) 0.81
Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells. J Immunol (1993) 0.81
Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression. Immunology (1994) 0.80
Tiazofurin induces a down-modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. Cell Immunol (1995) 0.80
Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms. J Immunol (1995) 0.80
The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens. Immunol Lett (1988) 0.79
Retroviral vector-mediated gene transfer into endothelial cells. Mol Biol Med (1991) 0.79
Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery (1992) 0.79
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (1984) 17.70
The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc (1999) 14.47
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Sequence and analysis of chromosome 2 of the plant Arabidopsis thaliana. Nature (1999) 8.04
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97
Guided medication dosing for inpatients with renal insufficiency. JAMA (2001) 6.25
The earliest angiosperms: evidence from mitochondrial, plastid and nuclear genomes. Nature (1999) 5.85
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics (1985) 5.30
Odds ratio or relative risk for cross-sectional data? Int J Epidemiol (1994) 5.27
Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science (1994) 5.20
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Structure and functional expression of a human interleukin-8 receptor. Science (1991) 4.74
Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol (1998) 4.54
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (1992) 4.53
Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Br J Ind Med (1993) 4.41
Glycosylation and the immune system. Science (2001) 4.39
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28
Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health (1993) 4.27
Identification of heregulin, a specific activator of p185erbB2. Science (1992) 4.17
Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J (1986) 3.78
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell (1995) 3.64
Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature (1997) 3.64
Exact confidence interval of the SMR based on prevalence data. Int J Epidemiol (1994) 3.62
Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med (1998) 3.59
Proliferation of mutators in A cell population. J Bacteriol (1997) 3.55
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (1990) 3.54
Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (1990) 3.44
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res (2001) 3.30
A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion. Chest (1998) 3.25
T-DNA insertional mutagenesis for functional genomics in rice. Plant J (2000) 3.25
The H2O2 stimulon in Saccharomyces cerevisiae. J Biol Chem (1998) 3.19
Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity (1996) 3.18
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res (2000) 3.12
NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol (1987) 3.06
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct (1979) 3.02
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc (2001) 2.98
Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments. Proc Natl Acad Sci U S A (1973) 2.96
Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord (2003) 2.89
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun (1995) 2.87
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86
Evidence-based disease management. JAMA (1997) 2.85
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene (2008) 2.83
Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit. Dev Dyn (2005) 2.71
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. Cancer Res (2001) 2.68
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
Protein structure prediction by global optimization of a potential energy function. Proc Natl Acad Sci U S A (1999) 2.66
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A (1988) 2.64
The Otto E. Aufranc Award: The role of labral lesions to development of early degenerative hip disease. Clin Orthop Relat Res (2001) 2.63
Qualitative interview study of communication between parents and children about maternal breast cancer. BMJ (2000) 2.60
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol (1999) 2.59
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57
HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 2.54
Forces exerted by locomoting cells. Semin Cell Biol (1994) 2.53
A delicate balance: homeostatic control of copper uptake and distribution. J Nutr (1999) 2.52
Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2001) 2.49
Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet (1996) 2.49
Local application of retinoic acid to the limb bond mimics the action of the polarizing region. Nature (1982) 2.48
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
Phytochrome signalling is mediated through nucleoside diphosphate kinase 2. Nature (1999) 2.46
Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development (2001) 2.43
Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A (2000) 2.40
Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A (1997) 2.39
Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care (2006) 2.35
Pain after breast surgery: a survey of 282 women. Pain (1996) 2.33
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci U S A (1989) 2.32
Recent improvements in prediction of protein structure by global optimization of a potential energy function. Proc Natl Acad Sci U S A (2001) 2.31
The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) (2014) 2.31
Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics (1988) 2.31
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol (1998) 2.28
Replacement of Aedes aegypti by Aedes albopictus in Mobile, Alabama. J Am Mosq Control Assoc (1991) 2.26
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A (1991) 2.25
Transfer of research-based HIV prevention interventions to community service providers: fidelity and adaptation. AIDS Educ Prev (2000) 2.23
DNA cleavage in trans by the active site tyrosine during Flp recombination: switching protein partners before exchanging strands. Cell (1992) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
Localisation of enzymic defect in propionicacidaemia. Lancet (1970) 2.19
Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J Immunol (1982) 2.18
Optimising delivery of care in coeliac disease - comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther (2013) 2.18
A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science (1997) 2.18
Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today (1992) 2.17
Defective antigen processing in GILT-free mice. Science (2001) 2.16
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
RIP3, a novel apoptosis-inducing kinase. J Biol Chem (1999) 2.15
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A (1997) 2.14
Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature (1991) 2.14
MAC1, a nuclear regulatory protein related to Cu-dependent transcription factors is involved in Cu/Fe utilization and stress resistance in yeast. EMBO J (1993) 2.13
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax (2004) 2.13
Complications of inguinoscrotal bladder hernias: a case series. Hernia (2008) 2.12
Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc Natl Acad Sci U S A (1994) 2.10